Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum
2024

Using Digital Solutions to Improve Heart Failure Treatment

Sample size: 266589 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R. Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill

Primary Institution: University of Twente

Hypothesis

Can digital solutions optimize guideline-directed medical therapy (GDMT) prescription rates in heart failure patients?

Conclusion

Digital solutions can significantly enhance the prescription rates of guideline-directed medical therapy for heart failure patients.

Supporting Evidence

  • Digital solutions can help clinicians see more patients efficiently.
  • Remote monitoring provides valuable data for optimizing treatment.
  • Clinical decision support systems can alert clinicians to medication needs.
  • Digital consults can improve patient access to care.
  • Studies show that digital interventions can increase GDMT prescription rates.
  • Multifaceted digital solutions are more effective than standalone interventions.
  • Patient engagement tools can enhance adherence to treatment.
  • Digital health technologies have gained popularity during the COVID-19 pandemic.

Takeaway

Doctors can use technology to help patients with heart failure get the right medicines more easily, which can make them feel better.

Methodology

The study reviews various digital solutions and their effectiveness in optimizing GDMT for heart failure patients, including data from the EVOLUTION HF study.

Potential Biases

Potential biases include clinician skepticism towards digital tools and variability in patient access to technology.

Limitations

The study highlights the variability in healthcare infrastructure and clinician practices that may affect the implementation of digital solutions.

Participant Demographics

The study includes heart failure patients from various countries, with a focus on those with reduced ejection fraction.

Statistical Information

P-Value

0.01

Confidence Interval

95% confidence interval: 0.31–0.49

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ehjdh/ztae064

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication